Sun Kissed Industries Inc. (OTC PINK: SKDI) , an emerging leader in the development and sale of CBD consumables, digital content management and online ad monetization technology today announced the completion of the Numuni acquisition, from online ad entrepreneur, Robert Reynolds.
The Global PC market, encompassing residential and commercial, is estimated to reach 251 million units in 2021 with total IT spending of $4 trillion. The US shipments for Q1 2020 were 11 million units. That is an almost unimaginable amount of computational power, most of which goes unused.
What is Numuni? ( https://numuni.io/ )
Numuni is a powerful monetization platform developed for digital media publishers, software providers, and online games. It enables the privacy-friendly monetization of users’ spare computer processing power, incentivizing participation through premium digital media content distribution. Numuni is a revolutionary solution to the increasing impotence of traditional digital advertising strategies. Freed resources are pooled to form a distributed supercomputer that can mine cryptocurrency, run scientific simulations, train AIs, perform 3D rendering, and undertake many more tasks.
Numuni’s modern GPU (graphical processing unit) network was designed from the ground up for massive parallel processing. Companies can remove the costly CPU performance constraints and take full advantage of unused GPU resources across the Numuni distributed network.
Per installation revenue estimates based on the over 6,000 beta tester installations and discussions with the Top 50 Global Websites put the figure at an ongoing $2 per month.
Robert Reynolds, CEO of Numuni, discussed the following in a recent podcast:
-His background through launching and ultimately selling of CPA Lead ($120m+ rev company, was Top 40th fastest growing company in the US)
-Numuni filling a growing industry need as ad revenue slows
-Monetization of the internet without ad flooding
-Building a distributed super computer using a websites’ existing user base
-3D rendering, complex data processing, cryptocurrency mining and more
Podcast link Anchor.FM: https://anchor.fm/stock-market-podcast
How does Numuni work?
The Numuni solution is advertised in key locations around the partner website. When members or visitors of the site click on the Numuni ad they are presented with the Numuni platform solution and an opportunity for them to share the unused portion of their PCs processing power to earn income or rewards while their machine is on. Partner websites may offer ‘ad-free’, ‘reduced-ad’, ‘exclusive access’ and more in return for installation of the Numuni platform.
Numuni CEO Robert Reynolds said “we here at our team at Numuni are so excited to be a part of the Sun Kissed vision. The success of our beta testing phase and move to an official launch has driven a significant increase in interest from ad partners, distributed computing resource clients, as well as consumers looking to benefit from the Numuni monetization platform.”
“Completion of the Numuni acquisition enhances Sun Kissed’s business model of targeted acquisitions. The Numuni platform could be applied by researchers, such as is needed with COVID-19 vaccine development, among many other uses. This is a game changer for the online ad revenue industry and the distributed computing sector.” commented Carl Grant, CEO of Sun Kissed.
KRONOS ADVANCED TECHNOLOGIES, INC., (OTC:KNOS) a product development and production company that has significantly changed the way air is moved, filtered and sterilized today announced that internationally-recognized businessman, veteran entrepreneur and inaugural Shark Tank investor Kevin Harrington, will star in our upcoming infomercials and has joined our Advisory Board.
An innovator in infomercial marketing and one of the original Sharks on the hit TV show Shark Tank, and pioneer of the As Seen On TV empire-Harrington has enabled countless entrepreneurs and business leaders to turn their ideas into reality. Throughout his corporate ventures, he has launched more than 500 products, driving over $5 billion in sales. In addition to being the Pioneer of the As Seen on TV brand, Kevin co-founded as board member the Entrepreneur’s Organization. Kevin Harrington has pushed past all of the questions and excuses -to repeatedly enjoy 100X successes. His legendary work behind-the-scenes of business ventures has produced well over $5 billion in global sales, the launch of more than 500 products, and the making of dozens of millionaires.
Twenty of his companies have each topped $100 million in revenue. (https://kevinharrington.tv)
Kronos also welcomes Mr. Steve Mandell – one of Harrington Group Expert Advisors as an independent Director. Steve Mandell, an entertainment and sports attorney and serial entrepreneur who is engaged in international business, will join on the Advisory Board. Steve has been involved with some of the biggest names in the sports and entertainment industry brokering thousands of transactions. Steve’s company has also been a licensee of the NFL, MLB, CNN, NHL , Caesars and more. He has been involved in all aspects of business development, digital branding and marketing, Steve has produced many products and has experience in selling through all channels of distribution including some of the largest big box stores. “I am honored to join the Kronos Team as an Advisor. The Kronos products have incorporated some of the most advanced technology in the world and I look forward to being a part of this forward thinking company. ”
CV Sciences, Inc. (OTC :CVSI) , a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that on May 19, 2020, the Company received its formal Notice of Issuance from the U.S. Patent and Trademark Office (USPTO) for its patent application 15/426,617.
The patent covers methods of treating smokeless tobacco addiction by administering pharmaceutical formulations containing CBD and nicotine. The communications between the USPTO and the Company conclude substantive examination of the patent application, resulting in formal issuance of the patent. CV Sciences has also filed corresponding patent applications that will allow the Company to seek similar patent protection in other key markets throughout the world.
The worldwide smokeless tobacco addiction treatment market is estimated at greater than $2 billion and provides another important long-term growth channel for CV Sciences, in addition to the Company’s consumer product segment.
“USPTO’s patent issuance demonstrates that our proprietary technology, the first-of-its-kind treatment for smokeless tobacco addiction, is based on unique science backed by years of research and development,” said Joseph Dowling, Chief Executive Officer, CV Sciences. “This intellectual property positions CV Sciences to derive significant value from our development efforts with an important therapeutic drug that has the potential to transform healthcare given the public health, societal and economic damage caused by nicotine addiction. With this patent, our years of investment, research and hard work is now validated, and we are well positioned and proud to take the next steps towards bringing to market an innovative solution to address a huge unmet medical need and global health issue.”